Interferon alpha-2b biosimilar - BiosidusAlternative Names: Bioferon; Biosidus interferon alpha 2b; Citopheron™; Ganapar™; Inter 2B™; Zavinex™
Latest Information Update: 20 Sep 2013
Price : *
At a glance
- Originator Biosidus S.A.
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer; Hepatitis B; Hepatitis C; Kaposi's sarcoma
Most Recent Events
- 17 Apr 2016 Biomarkers information updated
- 29 Apr 2013 Launched for Cancer in Thailand (Parenteral)
- 29 Apr 2013 Launched for Hepatitis B in Thailand (Parenteral)